Answers are grounded in this paper and cite their sources.
The regulatory landscape for artificial intelligence (AI) is shaping up on both sides of the Atlantic, urgently awaited by the scientific and industrial community. Commonalities and differences start to crystallize in the approaches to AI in medicine.
No takes yet. Share an insight, caveat, or question.
Vokinger et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: